Serum - Protection from birth onwards
For the use only of a Registered Medical Practitioner or a Hospital or a Laboratory.
ChAdOx1 nCoV- 19 Corona Virus Vaccine (Recombinant)
One dose (0.5 ml) contains:
ChAdOx1 nCoV- 19 Corona Virus Vaccine (Recombinant) 5 × 10viral particles (vp)
*Recombinant, replication-deficient chimpanzee adenovirus vector encoding the SARS-CoV-2 Spike (S) glycoprotein. Produced in genetically modified human embryonic kidney (HEK) 293 cells
This product contains genetically modified organisms (GMOs).
For the full list of excipients, see section 6.1.
Both COVISHIELD™ (manufactured by Serum Institute of India Pvt Ltd) and COVID-19 Vaccine AstraZeneca (manufactured by AstraZeneca) are ChAdOx1 nCoV- 19 Corona Virus Vaccines (Recombinant).